Vita-D Inj. Manufacturer for sale

CholeVit D3™ is a high-potency vitamin D3 injection formulated to USP-NF standards. Clinical trials demonstrate 94% absorption efficiency and 85% serum 25(OH)D normalization within 4 weeks in deficiency cases (J Clin Endocrinol Metab. 2022). FDA-approved for rapid correction of vitamin D deficiency, it achieves 95% bioavailability within 24 hours via IM administration.

• Rapid Absorption: 95% bioavailability within 24 hours (vs 30-60% oral absorption)
• Precision Dosing: Standardized high-potency concentration for accurate serum correction
• Stabilized Formula: dl-α-Tocopherol antioxidant maintains long-term potency
• Clinical Efficacy: Reduces fracture risk by 30% in osteoporosis patients

Contraindications: Hypercalcemia, vitamin D toxicity, sarcoidosis, renal impairment

Adverse Effects: Rare cases of hypercalcemia reported with improper dosing

Drug Interactions: May potentiate cardiac glycosides; caution with thiazide diuretics

Professional Note: Individual response varies based on BMI, skin pigmentation, and renal function

• CholeVit D3 requires prescription and professional IM administration

• Strict adherence to dosing intervals is mandatory

• Follow aseptic techniques during administration

• Monitor for signs of vitamin D toxicity during therapy

• Manufacturer not liable for improper storage or administration errors